Filing Details
- Accession Number:
- 0001562180-15-000601
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-24 09:37:43
- Reporting Period:
- 2015-07-23
- Filing Date:
- 2015-07-24
- Accepted Time:
- 2015-07-24 09:37:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1042021 | M Jeffrey Jonas | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-07-23 | 3,000 | $76.79 | 81,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $76.28 USD to $76.99 USD. The price reported above reflects the weighted average sale price.